Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects.

ABSTRACT: Background In women with congenital heart defects (CHD), changes in blood volume, heart rate, respiration, and edema during pregnancy may lead to increased risk of adverse outcomes and conditions. The American Heart Association recommends providers of pregnant women with CHD assess cardiac health and discuss risks and benefits of cardiac-related medications. We described receipt of American Heart Association-recommended cardiac evaluations, filled potentially teratogenic or fetotoxic (Food and Drug Administration pregnancy category D/X) cardiac-related prescriptions, and adverse conditions among pregnant women with CHD compared with those without CHD. Methods and Results Using 2007 to 2014 US healthcare claims data, we ascertained a retrospective cohort of women with and without CHD aged 1

SUBMITTER: Downing KF 

PROVIDER: S-EPMC7372719 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature